1 Market Overview

1.1 Product Overview and Scope of Antiprotozoal Drugs

1.2 Classification of Antiprotozoal Drugs by Type

1.2.1 Overview: Global Antiprotozoal Drugs Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Antiprotozoal Drugs Revenue Market Share by Type in 2021

1.2.3 Amoebic Dysentery

1.2.4 Antimalarial Drug

1.2.5 Leishmaniasis & Chagas Disease

1.3 Global Antiprotozoal Drugs Market by Application

1.3.1 Overview: Global Antiprotozoal Drugs Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospital

1.3.3 Clinic

1.4 Global Antiprotozoal Drugs Market Size & Forecast

1.5 Global Antiprotozoal Drugs Market Size and Forecast by Region

1.5.1 Global Antiprotozoal Drugs Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Antiprotozoal Drugs Market Size by Region, (2017-2022)

1.5.3 North America Antiprotozoal Drugs Market Size and Prospect (2017-2028)

1.5.4 Europe Antiprotozoal Drugs Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Antiprotozoal Drugs Market Size and Prospect (2017-2028)

1.5.6 South America Antiprotozoal Drugs Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Antiprotozoal Drugs Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Antiprotozoal Drugs Market Drivers

1.6.2 Antiprotozoal Drugs Market Restraints

1.6.3 Antiprotozoal Drugs Trends Analysis

2 Company Profiles

2.1 Sanofi

2.1.1 Sanofi Details

2.1.2 Sanofi Major Business

2.1.3 Sanofi Antiprotozoal Drugs Product and Solutions

2.1.4 Sanofi Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Sanofi Recent Developments and Future Plans

2.2 Akthelia Pharmaceuticals Ltd

2.2.1 Akthelia Pharmaceuticals Ltd Details

2.2.2 Akthelia Pharmaceuticals Ltd Major Business

2.2.3 Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Product and Solutions

2.2.4 Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Akthelia Pharmaceuticals Ltd Recent Developments and Future Plans

2.3 GlaxoSmithKline Plc

2.3.1 GlaxoSmithKline Plc Details

2.3.2 GlaxoSmithKline Plc Major Business

2.3.3 GlaxoSmithKline Plc Antiprotozoal Drugs Product and Solutions

2.3.4 GlaxoSmithKline Plc Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 GlaxoSmithKline Plc Recent Developments and Future Plans

2.4 Immuron Ltd

2.4.1 Immuron Ltd Details

2.4.2 Immuron Ltd Major Business

2.4.3 Immuron Ltd Antiprotozoal Drugs Product and Solutions

2.4.4 Immuron Ltd Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Immuron Ltd Recent Developments and Future Plans

2.5 Microbiotix Inc

2.5.1 Microbiotix Inc Details

2.5.2 Microbiotix Inc Major Business

2.5.3 Microbiotix Inc Antiprotozoal Drugs Product and Solutions

2.5.4 Microbiotix Inc Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Microbiotix Inc Recent Developments and Future Plans

2.6 Protein Potential LLC

2.6.1 Protein Potential LLC Details

2.6.2 Protein Potential LLC Major Business

2.6.3 Protein Potential LLC Antiprotozoal Drugs Product and Solutions

2.6.4 Protein Potential LLC Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Protein Potential LLC Recent Developments and Future Plans

2.7 Dr. Reddy’s Laboratories

2.7.1 Dr. Reddy’s Laboratories Details

2.7.2 Dr. Reddy’s Laboratories Major Business

2.7.3 Dr. Reddy’s Laboratories Antiprotozoal Drugs Product and Solutions

2.7.4 Dr. Reddy’s Laboratories Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Dr. Reddy’s Laboratories Recent Developments and Future Plans

2.8 Mission Pharmacal

2.8.1 Mission Pharmacal Details

2.8.2 Mission Pharmacal Major Business

2.8.3 Mission Pharmacal Antiprotozoal Drugs Product and Solutions

2.8.4 Mission Pharmacal Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Mission Pharmacal Recent Developments and Future Plans

2.9 Aceto Corp.

2.9.1 Aceto Corp. Details

2.9.2 Aceto Corp. Major Business

2.9.3 Aceto Corp. Antiprotozoal Drugs Product and Solutions

2.9.4 Aceto Corp. Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Aceto Corp. Recent Developments and Future Plans

2.10 Mylan Pharmaceuticals

2.10.1 Mylan Pharmaceuticals Details

2.10.2 Mylan Pharmaceuticals Major Business

2.10.3 Mylan Pharmaceuticals Antiprotozoal Drugs Product and Solutions

2.10.4 Mylan Pharmaceuticals Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Mylan Pharmaceuticals Recent Developments and Future Plans

2.11 Impax Laboratories

2.11.1 Impax Laboratories Details

2.11.2 Impax Laboratories Major Business

2.11.3 Impax Laboratories Antiprotozoal Drugs Product and Solutions

2.11.4 Impax Laboratories Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Impax Laboratories Recent Developments and Future Plans

2.12 Pfizer

2.12.1 Pfizer Details

2.12.2 Pfizer Major Business

2.12.3 Pfizer Antiprotozoal Drugs Product and Solutions

2.12.4 Pfizer Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Pfizer Recent Developments and Future Plans

2.13 Lupin Pharmaceuticals

2.13.1 Lupin Pharmaceuticals Details

2.13.2 Lupin Pharmaceuticals Major Business

2.13.3 Lupin Pharmaceuticals Antiprotozoal Drugs Product and Solutions

2.13.4 Lupin Pharmaceuticals Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Lupin Pharmaceuticals Recent Developments and Future Plans

2.14 Glenmark Pharmaceuticals

2.14.1 Glenmark Pharmaceuticals Details

2.14.2 Glenmark Pharmaceuticals Major Business

2.14.3 Glenmark Pharmaceuticals Antiprotozoal Drugs Product and Solutions

2.14.4 Glenmark Pharmaceuticals Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Glenmark Pharmaceuticals Recent Developments and Future Plans

2.15 Sun Pharmaceutical

2.15.1 Sun Pharmaceutical Details

2.15.2 Sun Pharmaceutical Major Business

2.15.3 Sun Pharmaceutical Antiprotozoal Drugs Product and Solutions

2.15.4 Sun Pharmaceutical Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Sun Pharmaceutical Recent Developments and Future Plans

2.16 Heritage Pharmaceuticals

2.16.1 Heritage Pharmaceuticals Details

2.16.2 Heritage Pharmaceuticals Major Business

2.16.3 Heritage Pharmaceuticals Antiprotozoal Drugs Product and Solutions

2.16.4 Heritage Pharmaceuticals Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Heritage Pharmaceuticals Recent Developments and Future Plans

2.17 Gilead Sciences

2.17.1 Gilead Sciences Details

2.17.2 Gilead Sciences Major Business

2.17.3 Gilead Sciences Antiprotozoal Drugs Product and Solutions

2.17.4 Gilead Sciences Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Gilead Sciences Recent Developments and Future Plans

2.18 Johnson & Johnson

2.18.1 Johnson & Johnson Details

2.18.2 Johnson & Johnson Major Business

2.18.3 Johnson & Johnson Antiprotozoal Drugs Product and Solutions

2.18.4 Johnson & Johnson Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 Johnson & Johnson Recent Developments and Future Plans

2.19 Bristol-Myers Squibb

2.19.1 Bristol-Myers Squibb Details

2.19.2 Bristol-Myers Squibb Major Business

2.19.3 Bristol-Myers Squibb Antiprotozoal Drugs Product and Solutions

2.19.4 Bristol-Myers Squibb Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.20 Profounda

2.20.1 Profounda Details

2.20.2 Profounda Major Business

2.20.3 Profounda Antiprotozoal Drugs Product and Solutions

2.20.4 Profounda Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.20.5 Profounda Recent Developments and Future Plans

2.21 Knight Therapeutics

2.21.1 Knight Therapeutics Details

2.21.2 Knight Therapeutics Major Business

2.21.3 Knight Therapeutics Antiprotozoal Drugs Product and Solutions

2.21.4 Knight Therapeutics Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.21.5 Knight Therapeutics Recent Developments and Future Plans

2.22 Albert David

2.22.1 Albert David Details

2.22.2 Albert David Major Business

2.22.3 Albert David Antiprotozoal Drugs Product and Solutions

2.22.4 Albert David Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.22.5 Albert David Recent Developments and Future Plans

2.23 Wanlong

2.23.1 Wanlong Details

2.23.2 Wanlong Major Business

2.23.3 Wanlong Antiprotozoal Drugs Product and Solutions

2.23.4 Wanlong Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.23.5 Wanlong Recent Developments and Future Plans

2.24 Fangsheng

2.24.1 Fangsheng Details

2.24.2 Fangsheng Major Business

2.24.3 Fangsheng Antiprotozoal Drugs Product and Solutions

2.24.4 Fangsheng Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.24.5 Fangsheng Recent Developments and Future Plans

2.25 KPC Pharmaceuticals

2.25.1 KPC Pharmaceuticals Details

2.25.2 KPC Pharmaceuticals Major Business

2.25.3 KPC Pharmaceuticals Antiprotozoal Drugs Product and Solutions

2.25.4 KPC Pharmaceuticals Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.25.5 KPC Pharmaceuticals Recent Developments and Future Plans

2.26 Guilin Pharmaceuticals

2.26.1 Guilin Pharmaceuticals Details

2.26.2 Guilin Pharmaceuticals Major Business

2.26.3 Guilin Pharmaceuticals Antiprotozoal Drugs Product and Solutions

2.26.4 Guilin Pharmaceuticals Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.26.5 Guilin Pharmaceuticals Recent Developments and Future Plans

2.27 Pude Pharmaceutica

2.27.1 Pude Pharmaceutica Details

2.27.2 Pude Pharmaceutica Major Business

2.27.3 Pude Pharmaceutica Antiprotozoal Drugs Product and Solutions

2.27.4 Pude Pharmaceutica Antiprotozoal Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.27.5 Pude Pharmaceutica Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Antiprotozoal Drugs Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Antiprotozoal Drugs Players Market Share in 2021

3.2.2 Top 10 Antiprotozoal Drugs Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Antiprotozoal Drugs Players Head Office, Products and Services Provided

3.4 Antiprotozoal Drugs Mergers & Acquisitions

3.5 Antiprotozoal Drugs New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Antiprotozoal Drugs Revenue and Market Share by Type (2017-2022)

4.2 Global Antiprotozoal Drugs Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Antiprotozoal Drugs Revenue Market Share by Application (2017-2022)

5.2 Global Antiprotozoal Drugs Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Antiprotozoal Drugs Revenue by Type (2017-2028)

6.2 North America Antiprotozoal Drugs Revenue by Application (2017-2028)

6.3 North America Antiprotozoal Drugs Market Size by Country

6.3.1 North America Antiprotozoal Drugs Revenue by Country (2017-2028)

6.3.2 United States Antiprotozoal Drugs Market Size and Forecast (2017-2028)

6.3.3 Canada Antiprotozoal Drugs Market Size and Forecast (2017-2028)

6.3.4 Mexico Antiprotozoal Drugs Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Antiprotozoal Drugs Revenue by Type (2017-2028)

7.2 Europe Antiprotozoal Drugs Revenue by Application (2017-2028)

7.3 Europe Antiprotozoal Drugs Market Size by Country

7.3.1 Europe Antiprotozoal Drugs Revenue by Country (2017-2028)

7.3.2 Germany Antiprotozoal Drugs Market Size and Forecast (2017-2028)

7.3.3 France Antiprotozoal Drugs Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Antiprotozoal Drugs Market Size and Forecast (2017-2028)

7.3.5 Russia Antiprotozoal Drugs Market Size and Forecast (2017-2028)

7.3.6 Italy Antiprotozoal Drugs Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Antiprotozoal Drugs Revenue by Type (2017-2028)

8.2 Asia-Pacific Antiprotozoal Drugs Revenue by Application (2017-2028)

8.3 Asia-Pacific Antiprotozoal Drugs Market Size by Region

8.3.1 Asia-Pacific Antiprotozoal Drugs Revenue by Region (2017-2028)

8.3.2 China Antiprotozoal Drugs Market Size and Forecast (2017-2028)

8.3.3 Japan Antiprotozoal Drugs Market Size and Forecast (2017-2028)

8.3.4 South Korea Antiprotozoal Drugs Market Size and Forecast (2017-2028)

8.3.5 India Antiprotozoal Drugs Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Antiprotozoal Drugs Market Size and Forecast (2017-2028)

8.3.7 Australia Antiprotozoal Drugs Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Antiprotozoal Drugs Revenue by Type (2017-2028)

9.2 South America Antiprotozoal Drugs Revenue by Application (2017-2028)

9.3 South America Antiprotozoal Drugs Market Size by Country

9.3.1 South America Antiprotozoal Drugs Revenue by Country (2017-2028)

9.3.2 Brazil Antiprotozoal Drugs Market Size and Forecast (2017-2028)

9.3.3 Argentina Antiprotozoal Drugs Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Antiprotozoal Drugs Revenue by Type (2017-2028)

10.2 Middle East & Africa Antiprotozoal Drugs Revenue by Application (2017-2028)

10.3 Middle East & Africa Antiprotozoal Drugs Market Size by Country

10.3.1 Middle East & Africa Antiprotozoal Drugs Revenue by Country (2017-2028)

10.3.2 Turkey Antiprotozoal Drugs Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Antiprotozoal Drugs Market Size and Forecast (2017-2028)

10.3.4 UAE Antiprotozoal Drugs Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Antiprotozoal Drugs Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Antiprotozoal Drugs Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Antiprotozoal Drugs Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Antiprotozoal Drugs Revenue (USD Million) by Region (2017-2022)

Table 5. Global Antiprotozoal Drugs Revenue Market Share by Region (2023-2028)

Table 6. Sanofi Corporate Information, Head Office, and Major Competitors

Table 7. Sanofi Major Business

Table 8. Sanofi Antiprotozoal Drugs Product and Solutions

Table 9. Sanofi Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Akthelia Pharmaceuticals Ltd Corporate Information, Head Office, and Major Competitors

Table 11. Akthelia Pharmaceuticals Ltd Major Business

Table 12. Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Product and Solutions

Table 13. Akthelia Pharmaceuticals Ltd Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. GlaxoSmithKline Plc Corporate Information, Head Office, and Major Competitors

Table 15. GlaxoSmithKline Plc Major Business

Table 16. GlaxoSmithKline Plc Antiprotozoal Drugs Product and Solutions

Table 17. GlaxoSmithKline Plc Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Immuron Ltd Corporate Information, Head Office, and Major Competitors

Table 19. Immuron Ltd Major Business

Table 20. Immuron Ltd Antiprotozoal Drugs Product and Solutions

Table 21. Immuron Ltd Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Microbiotix Inc Corporate Information, Head Office, and Major Competitors

Table 23. Microbiotix Inc Major Business

Table 24. Microbiotix Inc Antiprotozoal Drugs Product and Solutions

Table 25. Microbiotix Inc Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Protein Potential LLC Corporate Information, Head Office, and Major Competitors

Table 27. Protein Potential LLC Major Business

Table 28. Protein Potential LLC Antiprotozoal Drugs Product and Solutions

Table 29. Protein Potential LLC Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Dr. Reddy’s Laboratories Corporate Information, Head Office, and Major Competitors

Table 31. Dr. Reddy’s Laboratories Major Business

Table 32. Dr. Reddy’s Laboratories Antiprotozoal Drugs Product and Solutions

Table 33. Dr. Reddy’s Laboratories Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Mission Pharmacal Corporate Information, Head Office, and Major Competitors

Table 35. Mission Pharmacal Major Business

Table 36. Mission Pharmacal Antiprotozoal Drugs Product and Solutions

Table 37. Mission Pharmacal Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Aceto Corp. Corporate Information, Head Office, and Major Competitors

Table 39. Aceto Corp. Major Business

Table 40. Aceto Corp. Antiprotozoal Drugs Product and Solutions

Table 41. Aceto Corp. Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Mylan Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 43. Mylan Pharmaceuticals Major Business

Table 44. Mylan Pharmaceuticals Antiprotozoal Drugs Product and Solutions

Table 45. Mylan Pharmaceuticals Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Impax Laboratories Corporate Information, Head Office, and Major Competitors

Table 47. Impax Laboratories Major Business

Table 48. Impax Laboratories Antiprotozoal Drugs Product and Solutions

Table 49. Impax Laboratories Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Pfizer Corporate Information, Head Office, and Major Competitors

Table 51. Pfizer Major Business

Table 52. Pfizer Antiprotozoal Drugs Product and Solutions

Table 53. Pfizer Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Lupin Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 55. Lupin Pharmaceuticals Major Business

Table 56. Lupin Pharmaceuticals Antiprotozoal Drugs Product and Solutions

Table 57. Lupin Pharmaceuticals Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Glenmark Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 59. Glenmark Pharmaceuticals Major Business

Table 60. Glenmark Pharmaceuticals Antiprotozoal Drugs Product and Solutions

Table 61. Glenmark Pharmaceuticals Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Sun Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 63. Sun Pharmaceutical Major Business

Table 64. Sun Pharmaceutical Antiprotozoal Drugs Product and Solutions

Table 65. Sun Pharmaceutical Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Heritage Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 67. Heritage Pharmaceuticals Major Business

Table 68. Heritage Pharmaceuticals Antiprotozoal Drugs Product and Solutions

Table 69. Heritage Pharmaceuticals Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Gilead Sciences Corporate Information, Head Office, and Major Competitors

Table 71. Gilead Sciences Major Business

Table 72. Gilead Sciences Antiprotozoal Drugs Product and Solutions

Table 73. Gilead Sciences Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 75. Johnson & Johnson Major Business

Table 76. Johnson & Johnson Antiprotozoal Drugs Product and Solutions

Table 77. Johnson & Johnson Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 79. Bristol-Myers Squibb Major Business

Table 80. Bristol-Myers Squibb Antiprotozoal Drugs Product and Solutions

Table 81. Bristol-Myers Squibb Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 82. Profounda Corporate Information, Head Office, and Major Competitors

Table 83. Profounda Major Business

Table 84. Profounda Antiprotozoal Drugs Product and Solutions

Table 85. Profounda Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 86. Knight Therapeutics Corporate Information, Head Office, and Major Competitors

Table 87. Knight Therapeutics Major Business

Table 88. Knight Therapeutics Antiprotozoal Drugs Product and Solutions

Table 89. Knight Therapeutics Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 90. Albert David Corporate Information, Head Office, and Major Competitors

Table 91. Albert David Major Business

Table 92. Albert David Antiprotozoal Drugs Product and Solutions

Table 93. Albert David Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 94. Wanlong Corporate Information, Head Office, and Major Competitors

Table 95. Wanlong Major Business

Table 96. Wanlong Antiprotozoal Drugs Product and Solutions

Table 97. Wanlong Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 98. Fangsheng Corporate Information, Head Office, and Major Competitors

Table 99. Fangsheng Major Business

Table 100. Fangsheng Antiprotozoal Drugs Product and Solutions

Table 101. Fangsheng Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 102. KPC Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 103. KPC Pharmaceuticals Major Business

Table 104. KPC Pharmaceuticals Antiprotozoal Drugs Product and Solutions

Table 105. KPC Pharmaceuticals Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 106. Guilin Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 107. Guilin Pharmaceuticals Major Business

Table 108. Guilin Pharmaceuticals Antiprotozoal Drugs Product and Solutions

Table 109. Guilin Pharmaceuticals Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 110. Pude Pharmaceutica Corporate Information, Head Office, and Major Competitors

Table 111. Pude Pharmaceutica Major Business

Table 112. Pude Pharmaceutica Antiprotozoal Drugs Product and Solutions

Table 113. Pude Pharmaceutica Antiprotozoal Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 114. Global Antiprotozoal Drugs Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 115. Global Antiprotozoal Drugs Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 116. Breakdown of Antiprotozoal Drugs by Company Type (Tier 1, Tier 2 and Tier 3)

Table 117. Antiprotozoal Drugs Players Head Office, Products and Services Provided

Table 118. Antiprotozoal Drugs Mergers & Acquisitions in the Past Five Years

Table 119. Antiprotozoal Drugs New Entrants and Expansion Plans

Table 120. Global Antiprotozoal Drugs Revenue (USD Million) by Type (2017-2022)

Table 121. Global Antiprotozoal Drugs Revenue Share by Type (2017-2022)

Table 122. Global Antiprotozoal Drugs Revenue Forecast by Type (2023-2028)

Table 123. Global Antiprotozoal Drugs Revenue by Application (2017-2022)

Table 124. Global Antiprotozoal Drugs Revenue Forecast by Application (2023-2028)

Table 125. North America Antiprotozoal Drugs Revenue by Type (2017-2022) & (USD Million)

Table 126. North America Antiprotozoal Drugs Revenue by Type (2023-2028) & (USD Million)

Table 127. North America Antiprotozoal Drugs Revenue by Application (2017-2022) & (USD Million)

Table 128. North America Antiprotozoal Drugs Revenue by Application (2023-2028) & (USD Million)

Table 129. North America Antiprotozoal Drugs Revenue by Country (2017-2022) & (USD Million)

Table 130. North America Antiprotozoal Drugs Revenue by Country (2023-2028) & (USD Million)

Table 131. Europe Antiprotozoal Drugs Revenue by Type (2017-2022) & (USD Million)

Table 132. Europe Antiprotozoal Drugs Revenue by Type (2023-2028) & (USD Million)

Table 133. Europe Antiprotozoal Drugs Revenue by Application (2017-2022) & (USD Million)

Table 134. Europe Antiprotozoal Drugs Revenue by Application (2023-2028) & (USD Million)

Table 135. Europe Antiprotozoal Drugs Revenue by Country (2017-2022) & (USD Million)

Table 136. Europe Antiprotozoal Drugs Revenue by Country (2023-2028) & (USD Million)

Table 137. Asia-Pacific Antiprotozoal Drugs Revenue by Type (2017-2022) & (USD Million)

Table 138. Asia-Pacific Antiprotozoal Drugs Revenue by Type (2023-2028) & (USD Million)

Table 139. Asia-Pacific Antiprotozoal Drugs Revenue by Application (2017-2022) & (USD Million)

Table 140. Asia-Pacific Antiprotozoal Drugs Revenue by Application (2023-2028) & (USD Million)

Table 141. Asia-Pacific Antiprotozoal Drugs Revenue by Region (2017-2022) & (USD Million)

Table 142. Asia-Pacific Antiprotozoal Drugs Revenue by Region (2023-2028) & (USD Million)

Table 143. South America Antiprotozoal Drugs Revenue by Type (2017-2022) & (USD Million)

Table 144. South America Antiprotozoal Drugs Revenue by Type (2023-2028) & (USD Million)

Table 145. South America Antiprotozoal Drugs Revenue by Application (2017-2022) & (USD Million)

Table 146. South America Antiprotozoal Drugs Revenue by Application (2023-2028) & (USD Million)

Table 147. South America Antiprotozoal Drugs Revenue by Country (2017-2022) & (USD Million)

Table 148. South America Antiprotozoal Drugs Revenue by Country (2023-2028) & (USD Million)

Table 149. Middle East & Africa Antiprotozoal Drugs Revenue by Type (2017-2022) & (USD Million)

Table 150. Middle East & Africa Antiprotozoal Drugs Revenue by Type (2023-2028) & (USD Million)

Table 151. Middle East & Africa Antiprotozoal Drugs Revenue by Application (2017-2022) & (USD Million)

Table 152. Middle East & Africa Antiprotozoal Drugs Revenue by Application (2023-2028) & (USD Million)

Table 153. Middle East & Africa Antiprotozoal Drugs Revenue by Country (2017-2022) & (USD Million)

Table 154. Middle East & Africa Antiprotozoal Drugs Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Antiprotozoal Drugs Picture

Figure 2. Global Antiprotozoal Drugs Revenue Market Share by Type in 2021

Figure 3. Amoebic Dysentery

Figure 4. Antimalarial Drug

Figure 5. Leishmaniasis & Chagas Disease

Figure 6. Antiprotozoal Drugs Revenue Market Share by Application in 2021

Figure 7. Hospital Picture

Figure 8. Clinic Picture

Figure 9. Global Antiprotozoal Drugs Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Antiprotozoal Drugs Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Antiprotozoal Drugs Revenue Market Share by Region (2017-2028)

Figure 12. Global Antiprotozoal Drugs Revenue Market Share by Region in 2021

Figure 13. North America Antiprotozoal Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Antiprotozoal Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Antiprotozoal Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Antiprotozoal Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Antiprotozoal Drugs Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Antiprotozoal Drugs Market Drivers

Figure 19. Antiprotozoal Drugs Market Restraints

Figure 20. Antiprotozoal Drugs Market Trends

Figure 21. Sanofi Recent Developments and Future Plans

Figure 22. Akthelia Pharmaceuticals Ltd Recent Developments and Future Plans

Figure 23. GlaxoSmithKline Plc Recent Developments and Future Plans

Figure 24. Immuron Ltd Recent Developments and Future Plans

Figure 25. Microbiotix Inc Recent Developments and Future Plans

Figure 26. Protein Potential LLC Recent Developments and Future Plans

Figure 27. Dr. Reddy’s Laboratories Recent Developments and Future Plans

Figure 28. Mission Pharmacal Recent Developments and Future Plans

Figure 29. Aceto Corp. Recent Developments and Future Plans

Figure 30. Mylan Pharmaceuticals Recent Developments and Future Plans

Figure 31. Impax Laboratories Recent Developments and Future Plans

Figure 32. Pfizer Recent Developments and Future Plans

Figure 33. Lupin Pharmaceuticals Recent Developments and Future Plans

Figure 34. Glenmark Pharmaceuticals Recent Developments and Future Plans

Figure 35. Sun Pharmaceutical Recent Developments and Future Plans

Figure 36. Heritage Pharmaceuticals Recent Developments and Future Plans

Figure 37. Gilead Sciences Recent Developments and Future Plans

Figure 38. Johnson & Johnson Recent Developments and Future Plans

Figure 39. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 40. Profounda Recent Developments and Future Plans

Figure 41. Knight Therapeutics Recent Developments and Future Plans

Figure 42. Albert David Recent Developments and Future Plans

Figure 43. Wanlong Recent Developments and Future Plans

Figure 44. Fangsheng Recent Developments and Future Plans

Figure 45. KPC Pharmaceuticals Recent Developments and Future Plans

Figure 46. Guilin Pharmaceuticals Recent Developments and Future Plans

Figure 47. Pude Pharmaceutica Recent Developments and Future Plans

Figure 48. Global Antiprotozoal Drugs Revenue Share by Players in 2021

Figure 49. Antiprotozoal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 50. Global Top 3 Players Antiprotozoal Drugs Revenue Market Share in 2021

Figure 51. Global Top 10 Players Antiprotozoal Drugs Revenue Market Share in 2021

Figure 52. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 53. Global Antiprotozoal Drugs Revenue Share by Type in 2021

Figure 54. Global Antiprotozoal Drugs Market Share Forecast by Type (2023-2028)

Figure 55. Global Antiprotozoal Drugs Revenue Share by Application in 2021

Figure 56. Global Antiprotozoal Drugs Market Share Forecast by Application (2023-2028)

Figure 57. North America Antiprotozoal Drugs Sales Market Share by Type (2017-2028)

Figure 58. North America Antiprotozoal Drugs Sales Market Share by Application (2017-2028)

Figure 59. North America Antiprotozoal Drugs Revenue Market Share by Country (2017-2028)

Figure 60. United States Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Canada Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Mexico Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Europe Antiprotozoal Drugs Sales Market Share by Type (2017-2028)

Figure 64. Europe Antiprotozoal Drugs Sales Market Share by Application (2017-2028)

Figure 65. Europe Antiprotozoal Drugs Revenue Market Share by Country (2017-2028)

Figure 66. Germany Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. France Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. United Kingdom Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Russia Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Italy Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Asia-Pacific Antiprotozoal Drugs Sales Market Share by Type (2017-2028)

Figure 72. Asia-Pacific Antiprotozoal Drugs Sales Market Share by Application (2017-2028)

Figure 73. Asia-Pacific Antiprotozoal Drugs Revenue Market Share by Region (2017-2028)

Figure 74. China Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Japan Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. South Korea Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. India Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Southeast Asia Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Australia Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. South America Antiprotozoal Drugs Sales Market Share by Type (2017-2028)

Figure 81. South America Antiprotozoal Drugs Sales Market Share by Application (2017-2028)

Figure 82. South America Antiprotozoal Drugs Revenue Market Share by Country (2017-2028)

Figure 83. Brazil Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 84. Argentina Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 85. Middle East and Africa Antiprotozoal Drugs Sales Market Share by Type (2017-2028)

Figure 86. Middle East and Africa Antiprotozoal Drugs Sales Market Share by Application (2017-2028)

Figure 87. Middle East and Africa Antiprotozoal Drugs Revenue Market Share by Country (2017-2028)

Figure 88. Turkey Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 89. Saudi Arabia Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 90. UAE Antiprotozoal Drugs Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 91. Methodology

Figure 92. Research Process and Data Source